FOX 13 Tampa Bay on MSN
Air Force veteran left in constant pain after lung cancer diagnosis gets life back through trial at Moffitt
Jorge Manchola, a retired Air Force staff sergeant, was diagnosed with stage 4 lung cancer in 2023. The cancer had spread to ...
UF Health Cancer Institute researchers have discovered a small compound produced naturally by gut bacteria that doubled the ...
The early-stage clinical trial marks the first U.S. testing of Alveltamig, an immunotherapy designed to help the immune ...
A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...
InvestorsHub on MSN
ImmunityBio shares jump after Saudi approval of ANKTIVA for lung cancer
Shares of ImmunityBio (NASDAQ:IBRX) climbed 6% on Wednesday morning after the company said Saudi Arabia’s Food and Drug ...
July 7, 2025 – The FDA has granted quick approval to a first-of-its-kind pill for a type of lung cancer known as non-small-cell lung cancer (NSCLC). The drug, called sunvozertinib and sold as Zegfrovy ...
From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...
News-Medical.Net on MSN
Novel drug combination overcomes resistance in aggressive KRAS-mutated lung cancer
A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and ...
Johnson & Johnson currently boasts one of the largest lineups of multiple myeloma products. Since its first FDA approval of a drug for this type of blood cancer a decade ago, the pharmaceutical giant ...
A new report from the American Cancer Association predicts lung cancer will cause more deaths than any other in 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback